Clinical Trials in San Diego

Showing 4021-4040 of 13,210 trials

A Study of Ad26.COV2.S in Adults (COVID-19)

NCT04436276

The purpose of the study is to assess the safety, reactogenicity, and immunogenicity of Ad26.COV2.S at 2 dose levels, administered intramuscularly (IM) as a single-dose or 2-dose schedule, with a single booster vaccination administered in one cohort in healthy adults aged greater than or equal to (\>=) 18 to less than or equal to (\<=) 55 years and in adults aged \>= 65 years in good health with or without stable underlying conditions. The purpose of the study is also to assess the safety and reactogenicity of Ad26.COV2.S administered as ad hoc booster vaccination in healthy adults aged \>= 18 to \<= 55 years and in adults \>= 65 years in good health with or without stable underlying conditions.

Covid-19 Prevention

Janssen Vaccines & Prevention B.V.1,085 participantsStarted Jul 2020

San Diego, California, United States • Melbourne, Florida, United States • Peoria, Illinois, United States +9 more locations

COMPLETEDPhase 1/2< 1 mile

A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age

NCT05496231

The main purpose of this study was to evaluate the safety and reactogenicity of GlaxoSmithKline Biologicals SA (GSK)'s investigational adjuvanted human papillomavirus (HPV) vaccine formulations.

Cervical Intraepithelial Neoplasia

GlaxoSmithKline1,080 participantsStarted Aug 2022

San Diego, California, United States • San Diego, California, United States • Wheat Ridge, Colorado, United States +65 more locations

A Study of Ad26.COV2.S in Adults (COVID-19)

A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age

Find Trials by Condition in San Diego

Researchers At UC San Diego Are Learning About the Benefits of Human Milk and How It Influences Infant and Child Health

Avelumab in First-line NSCLC (JAVELIN Lung 100)

Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability

Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients

A Study of the Bruton's Tyrosine Kinase Inhibitor, PCI-32765 (Ibrutinib), in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma

Spinal Cord Stimulation vs. Medical Management for Low Back Pain (DISTINCT)

Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants

A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults

A Study of Guselkumab in Participants With Familial Adenomatous Polyposis

Antenatal Chlamydia Trachomatis and Neisseria Gonorrhoeae Testing to Prevent Adverse Neonatal Consequences

The ShortCut™ Study Protocol

An Observational Study of Beta-Blocker Use in Patients With COPD and Acute MI

A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody

Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures

Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients

Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS)

A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion

Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis